Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00108979
Status:
COMPLETED
Last Update Posted:
2012-03-05
First Post:
2005-04-21
Brief Title:
Study of Escitalopram in Adult Patients With Major Depressive Disorder
Sponsor:
Forest Laboratories
Organization:
Forest Laboratories
Study Overview
Official Title:
Double-Blind Study of Escitalopram in Adult Patients With Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Escitalopram is the S-enantiomer of citalopram Both escitalopram and citalopram are selective serotonin reuptake inhibitors SSRIs and are used to treat depression in adults This study is designed to evaluate the efficacy safety and pharmacoeconomics of escitalopram and an active comparator in patients with major depressive disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None